FIELD: medicine.
SUBSTANCE: present invention refers to medicine and pharmacology and concerns developing and producing medicinal agents including DHMEQ or its analogues which can be used for treating and/or preventing oncological, autoimmune or inflammatory diseases. Invention also refers to medicinal preparations containing the above medicinal agents in a liquid, soft or solid dosage form.
EFFECT: medicinal agents according to the invention are characterized by high efficacy and low toxicity, besides, the specified medicinal agents according to the invention have high stability and bioavailability.
7 cl, 4 dwg, 2 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICINE FOR BACTERIAL VAGINOSIS (VARIANTS) | 2007 |
|
RU2325148C1 |
METRONIDASOL-CONTAINING PREPARATION FOR TREATING EYE DISEASES | 2003 |
|
RU2235536C1 |
AGENT FOR ACCELERATING WOUND HEALING | 2003 |
|
RU2239415C1 |
OINTMENT WITH IONOL AND PROPOLIS EXTRACT FOR INFLAMMATORY GYNAECOLOGIC DISEASES | 2008 |
|
RU2372093C1 |
AGENT FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISEASE USING METRONIDAZOL AND OXYMETHYLURACIL | 2003 |
|
RU2241455C1 |
MEDICINAL PREPARATION FOR TREATING INFLAMMATORY DISEASES OF MOUTH CAVITY | 2003 |
|
RU2226383C1 |
OINTMENT WITH BEE MOTH LARVAE EXTRACT AND PROPOLIS EXTRACT FOR PREVENTION AND INTEGRATED TREATMENT OF VIRAL INFECTION | 2011 |
|
RU2477141C2 |
COMBINATION OF DEHYDROXYMETHYL EPOXYQUINOMYCIN (DHMEQ) AND CYTOSTATICS FOR TREATING OVARIAN CANCER | 2018 |
|
RU2704020C1 |
OINTMENT WITH FURACILIN, LIDOCAINE AND DIBUNOL FOR INTEGRATED TREATMENT OF MAXILLOFACIAL ABSCESSES AND PHLEGMONS | 2011 |
|
RU2438650C1 |
OINTMENT WITH FURACILIN, LIDOCAINE AND DIBUNOL FOR INTEGRATED TREATMENT OF MAXILLOFACIAL ABSCESSES AND PHLEGMONS | 2011 |
|
RU2456978C1 |
Authors
Dates
2019-10-22—Published
2018-11-09—Filed